RTZ

10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine

RTZ as a free ligand exists in 6 entries. Examples include: 6CSB 4IAA 4WNW

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name10-{2-[(2R)-1-methylpiperidin-2-yl]ethyl}-2-(methylsulfanyl)-10H-phenothiazine
Identifiers10-[2-[(1S,2R)-1-methylpiperidin-2-yl]ethyl]-2-methylsulfanyl-phenothiazine
FormulaC21 H26 N2 S2
Molecular Weight370.57
TypeNON-POLYMER
Isomeric SMILESCSc1ccc2Sc3ccccc3N(CC[C@H]3CCCCN3C)c2c1
InChIInChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3/t16-/m1/s1
InChIKeyKLBQZWRITKRQQV-MRXNPFEDSA-N

Chemical Details

Formal Charge0
Atom Count51
Chiral Atom Count1
Chiral AtomsCAP
Bond Count54
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00679 Different stereochemistry
NameThioridazine
Groupsapproved
DescriptionA phenothiazine antipsychotic used in the management of psychoses, including schizophrenia, and in the control of severely disturbed or agitated behavior. It has little antiemetic activity. Thioridazine has a higher incidence of antimuscarinic effects, but a lower incidence of extrapyramidal symptoms, than chlorpromazine. (From Martindale, The Extra Pharmacopoeia, 30th ed, p618)
Synonyms
  • 10-[2-(1-Methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine
  • 2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine
  • 3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine
  • Mallorol
  • Malloryl
SaltsThioridazine Hydrochloride
Brand Names
  • Mellaril
  • Mellaril Tab 100mg
  • Mellaril Tab 10mg
  • Mellaril Tab 200mg
  • Mellaril Tab 25mg
Affected OrganismHumans and other mammals
IndicationFor the treatment of schizophrenia and generalized anxiety disorder.
PharmacologyThioridazine is a trifluoro-methyl phenothiazine derivative intended for the management of schizophrenia and other psychotic disorders. Thioridazine has not been shown effective in the management of behaviorial complications in patients with mental retardation.
Mechanism of actionThioridazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; blocks alpha-adrenergic effect, depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.
Route of administrationOral
Categories
  • Alpha1 Antagonists
  • Antipsychotic Agents
  • Antipsychotic Agents (First Generation [Typical])
  • Central Nervous System Agents
  • Central Nervous System Depressants
ATC-CodeN05AC02
CAS number50-52-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682